original ) (raw )Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study
Luciana Gavernet
Journal of Chemical Information and Modeling, 2021
View PDFchevron_right
Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro
Prashant Gupta
Journal of Chemical Information and Modeling, 2021
View PDFchevron_right
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening
Salvatore Di Maro
Journal of Chemical Information and Modeling
View PDFchevron_right
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro
Davide Bassani
Pharmaceuticals, 2022
View PDFchevron_right
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking
Vladislav Naumovich
2020
View PDFchevron_right
In Search of Non-covalent Inhibitors of SARS-CoV-2 Main Protease: Computer Aided Drug Design Using Docking and Quantum Chemistry
Danil Kutov
Supercomputing Frontiers and Innovations
View PDFchevron_right
Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic dynamic, and ADMET profiling
Wojciech Kolodziejczyk
Journal of Biomolecular Structure and Dynamics
View PDFchevron_right
Initial study on SARS-CoV-2 main protease inhibition mechanism of some potential drugs using molecular docking simulation
toan tran quoc
Vietnam Journal of Science and Technology, 2020
View PDFchevron_right
Haste makes waste: A critical review of docking‐based virtual screening in drug repurposing for SARS‐CoV‐2 main protease (M‐pro) inhibition
Pol segura
Medicinal Research Reviews, 2021
View PDFchevron_right
Finding Potent Inhibitors Against SARS-CoV-2 Main Protease Through Virtual Screening, ADMET, and Molecular Dynamic Simulation Studies
Nisha Amarnath Jonniya
View PDFchevron_right
Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 Mpro
Venkateswara Talluri
Molecular Diversity
View PDFchevron_right
Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)
Hemant Darbari
Journal of Biomolecular Structure and Dynamics
View PDFchevron_right
In Silico Discovery of Novel Inhibitors Against Main Protease (Mpro) of SARS-CoV-2 Using Pharmacophore and Molecular Docking Based Virtual Screening from ZINC Database
Zeshan Haider
2020
View PDFchevron_right
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
MEHDI OUBAHMANE
Pharmaceuticals
View PDFchevron_right
Modelling of potentially promising SARS protease inhibitors
Dariusz Plewczynski
Journal of Physics: Condensed Matter, 2007
View PDFchevron_right
Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach
Youness El Bakri
Applied Biochemistry and Biotechnology
View PDFchevron_right
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
maryam olagunju
2020
View PDFchevron_right
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases
Rupal Ojha
Journal of Biomolecular Structure & Dynamics, 2020
View PDFchevron_right
Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Joana Godoy
Current Medicinal Chemistry, 2021
View PDFchevron_right
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
Alicia Alberto
Computational Biology and Chemistry, 2020
View PDFchevron_right
MOLECULAR DOCKING AND DYNAMIC SIMULATION-BASED SCREENING IDENTIFIES INHIBITORS OF TARGETED SARS-COV-2 3CLPRO AND HUMAN ACE2
International Journal of Applied Pharmaceutics (IJAP)
International Journal of Applied Pharmaceutics, 2023
View PDFchevron_right
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Reetikesh Patel
Journal of Infection and Public Health, 2020
View PDFchevron_right
Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach
Dr. Achintya Saha
Molecular Diversity
View PDFchevron_right
Optimization rules for SARS-CoV-2 M\u3csup\u3epro\u3c/sup\u3e antivirals: Ensemble docking and exploration of the coronavirus protease active site
Nowreen Sarwar
2020
View PDFchevron_right
Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19
Delaram Doroud
Gastroenterology and hepatology from bed to bench, 2020
View PDFchevron_right